☆ 4.7 Article

Immunogenicity and Neutralizing Activity Comparison of SARS-CoV-2 Spike Full-Length and Subunit Domain Proteins in Young Adult and Old-Aged Mice

VACCINES (2021)

相关参考文献

注意：仅列出部分参考文献，下载原文获取全部文献信息。

Article Virology

SARS-CoV-2 S1 is superior to the RBD as a COVID-19 subunit vaccine antigen

Yunfei Wang et al.

Summary: The S1 domain of SARS-CoV-2 induces higher levels of antibodies in mice and efficiently neutralizes the virus when adjuvanted with alum. Research suggests that expression systems with posttranslational modification abilities and adjuvants prone to a Th1 response are crucial for effective COVID-19 vaccines.

JOURNAL OF MEDICAL VIROLOGY (2021)

添加到收藏夹

Article Microbiology

Intranasal vaccination with a lentiviral vector protects against SARS-CoV-2 in preclinical animal models

Min-Wen Ku et al.

Summary: Vaccination using a lentiviral vector to induce neutralizing antibodies against SARS-CoV-2 provides partial protection when administered systemically, but intranasal immunization results in a significant decrease in lung viral load and reduced local inflammation. Integrative and non-integrative lentiviral platforms both show strong vaccine efficacy against COVID-19 in golden hamsters, highlighting the potential of intranasal vaccination as a powerful approach.

CELL HOST & MICROBE (2021)

添加到收藏夹

Article Multidisciplinary Sciences

A single-dose live-attenuated YF17D-vectored SARS-CoV-2 vaccine candidate

Lorena Sanchez-Felipe et al.

Summary: The candidate vaccine YF-S0, utilizing the YF17D vaccine as a vector to express noncleavable prefusion form of the SARS-CoV-2 spike antigen, showed excellent safety, immunogenicity, and efficacy in animal models. It induced high levels of neutralizing antibodies, provided protective immunity against SARS-CoV-2, and prevented infection in hamsters and macaques. A single dose was able to confer protection from lung disease in most vaccinated hamsters within 10 days, highlighting the potential of YF-S0 as a potent SARS-CoV-2 vaccine candidate.

NATURE (2021)

添加到收藏夹

Article Immunology

A modified vaccinia Ankara vector-based vaccine protects macaques from SARS-CoV-2 infection, immune pathology, and dysfunction in the lungs

Nanda Kishore Routhu et al.

Summary: The study demonstrates that MVA/S vaccination induces strong neutralizing antibody and T cell responses, providing protection against SARS-CoV-2 in mice and macaques. Single-cell RNA sequencing analysis of lung cells reveals that the vaccination also protects macaques from infection-induced inflammation and B cell abnormalities.

IMMUNITY (2021)

添加到收藏夹

Review Immunology

Mini Review Immunological Consequences of Immunization With COVID-19 mRNA Vaccines: Preliminary Results

Andrea Lombardi et al.

Summary: BNT162b2 and mRNA-1273 vaccines can elicit specific antibodies and neutralizing antibodies levels higher than those observed in convalescent serum of COVID-19 patients within the first 100 days after vaccination, with a reassuring safety and efficacy profile. The vaccine-induced T cell response is oriented towards a beneficial T(H)1 response, without evidence of vaccine-enhanced disease reported.

FRONTIERS IN IMMUNOLOGY (2021)

添加到收藏夹

Review Immunology

COVID-19 Vaccines (Revisited) and Oral-Mucosal Vector System as a Potential Vaccine Platform

Muhammad Umer Ashraf et al.

Summary: There are various emerging vaccination strategies for COVID-19, but selecting the most effective one remains a challenge; over 200 vaccines are being tested globally, with more than 50 clinical trials underway; a diverse range of vaccine candidate platforms are being evaluated, including the potential for a new oral mucosal COVID-19 vaccine.

VACCINES (2021)

添加到收藏夹

Article Immunology

Neutralizing Antibody Responses in COVID-19 Convalescent Sera

William T. Lee et al.

Summary: Passive transfer of antibodies from COVID-19 convalescent patients is used as an experimental treatment for SARS-CoV-2 infections. As time post symptom onset increases, neutralizing activity in sera significantly rises to reach a peak, emphasizing the value of serum characterization for neutralization activity.

JOURNAL OF INFECTIOUS DISEASES (2021)

添加到收藏夹

Article Medicine, General & Internal

Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding

Roujian Lu et al.

LANCET (2020)

添加到收藏夹

Article Multidisciplinary Sciences

A new coronavirus associated with human respiratory disease in China

Fan Wu et al.

NATURE (2020)

添加到收藏夹

Article Multidisciplinary Sciences

A pneumonia outbreak associated with a new coronavirus of probable bat origin

Peng Zhou et al.

NATURE (2020)

添加到收藏夹

Review Allergy

Immune response to SARS-CoV-2 and mechanisms of immunopathological changes in COVID-19

Ahmet Kursat Azkur et al.

ALLERGY (2020)

添加到收藏夹

Article Biochemistry & Molecular Biology

Structure, Function, and Antigenicity of the SARS-CoV-2 Spike Glycoprotein

Alexandra C. Walls et al.

CELL (2020)

添加到收藏夹

Article Multidisciplinary Sciences

DNA vaccine protection against SARS-CoV-2 in rhesus macaques

Jingyou Yu et al.

SCIENCE (2020)

添加到收藏夹

Article Multidisciplinary Sciences

Two linear epitopes on the SARS-CoV-2 spike protein that elicit neutralising antibodies in COVID-19 patients

Chek Meng Poh et al.

NATURE COMMUNICATIONS (2020)

添加到收藏夹

Article Multidisciplinary Sciences

Characterization of spike glycoprotein of SARS-CoV-2 on virus entry and its immune cross-reactivity with SARS-CoV

Xiuyuan Ou et al.

NATURE COMMUNICATIONS (2020)

添加到收藏夹

Article Medicine, General & Internal

Remdesivir for the Treatment of Covid-19-Final Report

John H. Beigel et al.

NEW ENGLAND JOURNAL OF MEDICINE (2020)

添加到收藏夹

Article Medicine, General & Internal

Observational Study of Hydroxychloroquine in Hospitalized Patients with Covid-19

Joshua Geleris et al.

NEW ENGLAND JOURNAL OF MEDICINE (2020)

添加到收藏夹

Article Biochemistry & Molecular Biology

Potent Neutralizing Antibodies against SARS-CoV-2 Identified by High-Throughput Single-Cell Sequencing of Convalescent Patients' B Cells

Yunlong Cao et al.

CELL (2020)

添加到收藏夹

Article Multidisciplinary Sciences

SARS-CoV-2 mRNA vaccine design enabled by prototype pathogen preparedness

Kizzmekia S. Corbett et al.

NATURE (2020)

添加到收藏夹

News Item Multidisciplinary Sciences

STEROID IS FIRST DRUG SHOWN TO PREVENT DEATHS FROM COVID-19

Heidi Ledford

NATURE (2020)

添加到收藏夹

Article Cell Biology

Antibody signature induced by SARS-CoV-2 spike protein immunogens in rabbits

Supriya Ravichandran et al.

SCIENCE TRANSLATIONAL MEDICINE (2020)

添加到收藏夹

Article Microbiology

Neutralizing Antibodies Correlate with Protection from SARS-CoV-2 in Humans during a Fishery Vessel Outbreak with a High Attack Rate

Amin Addetia et al.

JOURNAL OF CLINICAL MICROBIOLOGY (2020)

添加到收藏夹

Review Multidisciplinary Sciences

SARS-CoV-2 vaccines in development

Florian Krammer

NATURE (2020)

添加到收藏夹

Article Medicine, General & Internal

Safety and Immunogenicity of Two RNA-Based Covid-19 Vaccine Candidates

Edward E. Walsh et al.

NEW ENGLAND JOURNAL OF MEDICINE (2020)

添加到收藏夹

Article Medicine, General & Internal

Phase 1-2 Trial of a SARS-CoV-2 Recombinant Spike Protein Nanoparticle Vaccine

Cheryl Keech et al.

NEW ENGLAND JOURNAL OF MEDICINE (2020)

添加到收藏夹

Article Biochemistry & Molecular Biology

RBD-Fc-based COVID-19 vaccine candidate induces highly potent SARS-CoV-2 neutralizing antibody response

Zezhong Liu et al.

SIGNAL TRANSDUCTION AND TARGETED THERAPY (2020)

添加到收藏夹

Article Biochemistry & Molecular Biology

Elicitation of Potent Neutralizing Antibody Responses by Designed Protein Nanoparticle Vaccines for SARS-CoV-2

Alexandra C. Walls et al.

CELL (2020)

添加到收藏夹

Review Biochemistry & Molecular Biology

A systematic review of SARS-CoV-2 vaccine candidates

Yetian Dong et al.

SIGNAL TRANSDUCTION AND TARGETED THERAPY (2020)

添加到收藏夹

Review Chemistry, Medicinal

SARS-CoV-2 Vaccine Development: An Overview and Perspectives

Yi Liu et al.

ACS PHARMACOLOGY & TRANSLATIONAL SCIENCE (2020)

添加到收藏夹

Review Pharmacology & Pharmacy

Shingrix: The New Adjuvanted Recombinant Herpes Zoster Vaccine

Stephanie F. James et al.

ANNALS OF PHARMACOTHERAPY (2018)

添加到收藏夹

Review Immunology

Adjuvant system AS01: helping to overcome the challenges of modern vaccines

Arnaud M. Didierlaurent et al.

EXPERT REVIEW OF VACCINES (2017)

添加到收藏夹

Article Immunology

Cellular and molecular synergy in AS01-adjuvanted vaccines results in an early IFNγ response promoting vaccine immunogenicity

Margherita Coccia et al.

NPJ VACCINES (2017)

添加到收藏夹

Article Medicine, General & Internal

Efficacy of an Adjuvanted Herpes Zoster Subunit Vaccine in Older Adults

Himal Lal et al.

NEW ENGLAND JOURNAL OF MEDICINE (2015)

添加到收藏夹

Article Virology

Recombinant receptor-binding domain of SARS-CoV spike protein expressed in mammalian, insect and E. coli cells elicits potent neutralizing antibody and protective immunity

Lanying Du et al.

VIROLOGY (2009)

添加到收藏夹

© Peeref 2019-2024. All rights reserved.